北京招聘

Who We Are

Predicine is an international precision medicine organization that is committed to developing the first- and best-in-class precision diagnostics and precision medicine portfolio to address the unmet medical needs in the China, US and worldwide. We aim to provide innovative non-invasive diagnostic tests to enable precision medicine. Please take this opportunity to learn about Predicine, where we believe people are our most important asset and are dedicated to creating a great place to work. At Predicine, we value a culture of creativity, integrity, responsibility, productivity, and teamwork. We invite people who share the same values to join us. Predicine operates in Shanghai China and Silicon Valley, USA.

The Position

We seek a highly motivated and talented individual responsible for developing business with pharmaceutical customers and hospitals in China. Based in Shanghai, this position will be a key member of Predicine’s Global Business Development team.

?The candidate must be able to operate in a fast-paced organization and have extremely high standards and accountability on quality of deliverables. ??

As a VP/Director /Associate Director, you are expected to:

Provide exceptional leadership for translating innovative blood test to advance clinical biomarker assessment in personalized cancer care and oncology clinical trials

Identify, lead and drive business opportunities with customers and support biomarker-oriented precision medicine and clinical drug development across all stages

Provide exceptional business leadership within company, particularly to groups of other functions in product development

Participate in, or lead, disease focused translational biomarker products, and support on scientific and technical innovation collaboratively with other members of the company

Prepare high quality scientific, technical or medical materials

Represent the company externally through presentations at key National / International meetings, interactions with key partners

Participate and thrive in a past-paced, interactive, team oriented culture

Who you are: In adding new members to our team, we look for people who are inspired by our mission and who would fit in well with the collaborative, rigorous and entrepreneurial spirit of the company culture. Because we know that people are critical to our success in business, we are dedicated to creating a great place to work and to providing people with programs, services and benefits that allow them to bring the best to the business and to their personal and professional growth.

??BA, MS, PhD, or MD degree in a relevant scientific field (e.g. pathology, molecular biology, cancer genetics, cancer biology, molecular oncology). ??

Minimum of 5 years experience in sales, marketing, business development, and basic, clinical or translational research either in an academic and/or industry setting

Experience in clinical practice or drug development is beneficial, including basic or advanced understanding of critical development functions, e.g. oncology biomarker development, clinical trials, targeted therapy, etc.

Outstanding presentation and communication skills

Ability to lead, influence and motivate others

Able to distill complex issues and clearly articulate solutions

Ability to demonstrate effectiveness and growth in a fast-paced and dynamic environment

Travel required

This is an exciting opportunity to participate in, and to enable, our vision of transforming healthcare through development of innovative technologies. If you are looking for opportunities to make a positive and immediate impact on the society, please submit cover letter and resume to: contact@predicine.com, www.predicine.com.

      慧渡医疗是一家专注于精准医疗的国际高科技集团公司，在美国硅谷和中国上海同步运营。团队成员来自于全球***的工业界和学术界，开发出第二代基于RNA和DNA联合检测的液态活检技术，应用于新药临床试验、癌症早筛和临床用药指导。日前与多家国际药企、医院、大学、政府和全球健康产业的相关机构开展全方位的战略和业务合作。
      在新药临床试验和医院临床科研方面，慧渡医疗推出ctRNA+ctDNA联合液态活检解决方案，成功实现对癌症患者的无创伤诊断、靶向用药指导、疗效动态监控和抗药性分子机制的分析。为加速新药临床试验，Predicine（慧渡医疗）推出了“精准临床试验的全球解决方案”。通过在美国硅谷和中国上海的CLIA和CAP国际标准实验室，提供一站式、全方位的生物标记物检测、生物信息学和数据解读的综合平台。目前慧渡医疗（Predicine）已经与28家国际知名药企（包括8家世界500强企业）开展基于生物标记物的精准新药临床试验，支持在中国-美国-欧洲-亚洲-澳洲同步进行的国际多中心新药临床试验。